Update on continuous estrogen-progestin replacement therapy

J. A. Rosenfeld

Research output: Contribution to journalReview article

Abstract

Estrogen replacement therapy is recommended for the prevention of osteoporosis and the attenuation of symptoms associated with menopause. Compliance may be a problem with sequential regimens of estrogen and progestin. To address this issue, continuous-dosing regimens of estrogen and progestin have been used. These regimens cause significantly less cyclic and intermenstrual bleeding and induce amenorrhea in most women, which should enhance compliance.

Original languageEnglish (US)
Pages (from-to)1519-1523
Number of pages5
JournalAmerican family physician
Volume50
Issue number7
StatePublished - Dec 14 1994

ASJC Scopus subject areas

  • Family Practice

Fingerprint Dive into the research topics of 'Update on continuous estrogen-progestin replacement therapy'. Together they form a unique fingerprint.

  • Cite this